WILMINGTON – Synnovation Therapeutics will ask the state’s Council on Development Finance on Monday for a $438,000 Strategic Fund grant to help the cancer research company nearly triple its workforce, according to an application obtained under the Freedom of Information Act (FOIA). Synnovation is a Wilmington-based cancer research company formed in August 2021. It was…
